1-(3-Fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine

Catalog No. :
ACITUX154
CAS No. :
845616-81-1
Molecular Formula :
C10H11F4N3
Molecular Weight :
249.21

IUPAC Name:1-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine

1-(3-Fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$89.00Login to see priceIn stockInquiry
250mg98%$182.00Login to see priceIn stockInquiry
1g98%$474.00Login to see priceIn stockInquiry
5g98%$1665.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine
IUPAC Name1-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine
MDL No.MFCD16658804
Molecular FormulaC10H11F4N3
Molecular Weight249.21
SMILESFC(C1=CN=C(N2CCNCC2)C(F)=C1)(F)F
InChI KeyMUONIPDFCCBLEH-UHFFFAOYSA-N
Synonym1-(3-Fluoro-5-trifluoroMethylpyridin-2-yl)piperazine;1-(3-Fluoro-5-trifluoroMethylpyridin-2-yl);1-[3-Fluoro-5-(trifluoromethyl)-2-pyridinyl]piperazine;Piperazine, 1-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]-;3-Fluoro-2-(piperazin-1-yl)-5-(trifluoromethyl)pyridine
CAS No.845616-81-1

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACITUX154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACITUX154 route product structure diagram
    ACITUX154845616-81-1 In Stock
Inquiry

2. ACITUX154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACITUX154 route product structure diagram
    ACITUX154845616-81-1 In Stock
Inquiry

Comments (0)